The entire Aniara line is available for purchase at http://www.aniara.com.
WEST CHESTER, Ohio (PRWEB) April 21, 2020
Aniara Diagnostica is pleased to announce the availability of Biophen™ FXIII chromogenic method for determination of FXIII.
Aniara Diagnostica, a multi-national distributor of diagnostic and research agents, as well as screening tools, has strengthened its commitment to meeting today’s highest standards for product quality and cost-efficient delivery.
For Research Use Only. Not for Use in Diagnostic Procedures.
BIOPHEN™ Factor XIII kit is a chromogenic method proposed for in vitro quantitative determination of Factor XIII activity in human citrated plasma.
227005 Biophen™ FXIII click here for more information.
The entire Aniara product line is available for purchase at http://www.aniara.com. The Company distributes products in North America, Central America, South America, Sweden, Norway, Denmark, Finland, Lithuania, Latvia, Estonia and Iceland.